The Indian government is working on creating an indigenous software system for drug monitoring through the Pharmacovigilance Program of India (PvPI), said Y K Gupta, national scientific coordinator of PvPI.
At present, the information on Adverse Drug Reaction (ADR) gathered from the patients across the country is entered into Vigiflow, a software analyzed at Indian Pharmacopoeia Commission (IPC).
Inaugurating a workshop on the subject in Chennai last day, Gupta said that with 21% of global pharmacovigilance data from India, the new system can be used to develop strategies for risk identification and minimization.
The Vigiflow system is maintained free of cost by Uppsala Monitoring Center (UMC) in Sweden.
"Now with adequate financial support from the government, the role of PvPI would be on focusing on several challenges in front of them," said Gupta, adding that the primary focus would be on developing a locally accessible pharmacovigilance database to monitor adverse drug reactions.
Stressing the significance for training programs for undergraduates on basic pharmacovigilance sensitization, Gupta said, "Despite the Medical Council of India making mandatory for all medical colleges to have a pharmacovigilance unit, the staff are not aware about its significance and shyness, fear of litigation and lack of interest among 99% clinicians to report ADR by spending enough time are the main issues to be resolved to overcome these challenges."